Integrat Respir Med
Volume 1, 2020
Topical Issue - Integrative Respiratory Medicine for COVID-19
|Number of page(s)||5|
|Published online||29 September 2020|
Advances in treatment of COVID-19
Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing 210029, China
2 Department of Physiology, Xuzhou Medical University, Xuzhou 221009, China
3 Department of Respiratory Medicine, Jiangsu Province Hospital of Chinese Medicine, Nanjing 210029, China
* Corresponding author: firstname.lastname@example.org
Accepted: 25 July 2020
The novel coronavirus pneumonia is an acute infectious disease caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The global pandemic of this novel coronavirus pneumonia has greatly threatened human health and brought enormous economy losses. By the end of May 20, 2020, the pandemic of this disease had caused more than 2.70 million infections and more than 320 thousand deaths. This paper reviewed the recent advances in the treatment of the novel coronavirus pneumonia to provide basic references for disease control.
Key words: Novel coronavirus pneumonia / COVID⁃19 / Therapeutic drug
© Q. Wu et al., Published by EDP Sciences, 2020
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.